Biopolymers in Focus: A Comprehensive Review of Natural Macromolecules

Author

More Omkar Shashikant, Radhika S. Subhedar, Nilesh B. Chougule


Abstract

 The essential components of every drug formulation consist of the active ingredient along with excipients. Excipients are substances that support the manufacture of dosage forms and enhance their physicochemical characteristics. In drug dosage forms, polymers serve as essential excipients. They exert a considerable influence on drug release and need to possess qualities including compatibility, non-toxicity, stability, and cost-effectiveness. Polymers are generally grouped into three categories: natural, semi-synthetic, and synthetic. In oral drug delivery systems, natural polymers are commonly employed as rate-controlling devices, for concealing unpleasant tastes, and for stabilizing, protecting, and encapsulating formulations. Cosmetic formulations that contain synthetic and/or semi-synthetic polymers, whether used alone or combined with natural polymers, feature an appealing design and are sensitive to heat and chemicals.  



Keywords

Natural Polymers, Biopolymers, Oral drug delivery system, Physicochemical Parameter, Adhesive



Full Text:

Download Paper PDF


References


  1. Bajpai, AK., Choubey, J. (2005). A study examining how the release of sulphathiazole is regulated through the swelling behavior of gelatine nanoparticles alongside the interaction occurring between the drug and the biopolymer, published in J. macro-Galuski. 42:253-275.
  2. Alleman, E., Doelker, E. (2005). Nanoparticles of poly (D, L-lactide-co-glycoside) that carry protein and are produced via the double emulsion technique—considerations relating to processing and formulation for achieving improved entrapment efficiency. J Microencapsulate .22:205-214.
  3. Campbell, K., Qi, S., Craig, DQM., McNally, T. (2009). Nanocomposites consisting of paracetamol-loaded poly ($
  4. \Var epsilon $-caprolactone) and layered silicate, which were fabricated through the use of hotmelt extrusion. J Pharm Sci. 98:4831-4843.
  5. Chorny, M., Hood, E., Levy, RJ. (2010). Delivery to the endothelium of antioxidant enzymes that have been incorporated into non-polymeric magnetic nanoparticles. J Control Release. 146:144-151.
  6. Coester, C., Kreuter, J., Von BH., Langer, K. (2000). The creation of gelatine nanoparticles that have been tagged with avidin, so that they can act as carriers for biotinylated peptide nucleic acid (PNA). Int J Pharm. 196:147-149. 6. Cole, AJ., David, AE., Wang, J., Galban, CJ., Yang, VC. (2011). The use of magnets to target brain tumors, together with an investigation into how iron oxide nanoparticles that circulate for a long time, are coated with starch, and have been modified with PEG, are distributed throughout the body. Biomaterials 32:6291-6301.
  7. Coviello, T., Matricardi, P., Marinucci, C., Ashanique, F. (2007). Hydrogels that are produced from polysaccharides, intended for use in formulations that provide modified release. J Control Release 119:5-24.
  8. Crommelin, DJA., Storm, G., Josko, W., Steineke, R., Mastrobattista, E et al. (2003). The application of nanotechnology as a means of delivering macromolecules. J Control Release 87:8188.
  9. Clochard, M., Dinan, E., Rankin, S., Simic, S., Brocchini, S., New strategies for polymer development in pharmaceutical science—a short review, J Pharm Pharmocol, 2001, 53(9),1175- 1184.
  10. Das, PR., Nanda, RM., Behara, A., Nayak, PR. (2011). By combining gelatine with cloisite30B nanoparticles (MMT), a system was created that is capable of delivering the anticancer drug paclitaxel in a controlled and sustained manner. International Research Journal of Biochemistry and Bioinformatics 1:35-42.
  11. Dev, A., Biunial, NS., Anitha, A., Nair, SV., Furuike, T et al. (2010). The fabrication of poly (lactic acid)/chitosan nanoparticles was carried out for the purpose of delivering anti-HIV drugs, as described in volume 80, pages 833-838.
  12. Dzyuba, TD., Karim, A., Miyanto, VR. (2005). Polymeric nanocarriers were designed to protect active enzyme cargo from being broken down by proteolysis. J Control Release 102:427439.
  13. Farrokhzad, OC., Langer, R. (2009). The impact that nanotechnology has had on the field of drug delivery is examined. ACS Nano, 3:16-20.
  14. Freemantle, M. (2005). Polymers that are utilized for the purpose of delivering drugs. Chemical & amp; Engineering News, volume 83, pages 45 to 47.
  15. Fritz, HG., and Widmann, B. (1993). Modification of Synthetic Polymers Through the Use of Native Starch. Starch-Starke, volume 45, pages 314 to 322.
  16. Guzman, KAD., Taylor, MR., and Banfield, JF. (2006). Environmental Risks Associated with Nanotechnology: Funding from the National Nanotechnology Initiative, 2000−2004. Environmental Science & amp; Technology, volume 40, pages 1401 to 1407.
  17. Omegathon Pillai and Ramesh, Polymers in drug delivery, Current Opinion in Chemical Biology, Volume 5, Issue 4, 2001, pages 447 to 451.
  18. Vicky V. Mody, Introduction to Polymeric Drug Delivery, Internet Journal of Medical Update, 5(2): July 2010; pages 1 to 2.
  19. Vyas SP and Khar RK. Controlled Drug Delivery: Concepts and Advances. First edition. Vallabh Prakashan, New Delhi, 2002, pages 156 to 189. Kathryn E. Uhrich and Skott.
  20. Cannizzaro and Robert S. Langer, Polymeric Systems for Controlled Drug Release, Chem. REV., 9, pages 3181 to 3198.

 

Share your valuable work from Social Media Buttons